China NMPA Product Recall - Ventilator

Respironics California, Inc., in collaboration with its distributor Philips (China) Investment Co., Ltd., initiated a voluntary Class I recall for specific ventilator models. This action, announced by the National Medical Products Administration (NMPA) on June 5, 2017, addresses a critical safety concern. It was reported that pins within the internal ribbon cable of the ventilators might become partially displaced due to low-frequency vibration, potentially leading to device errors and unexpected shutdowns. This issue presents a significant risk to patient safety. The recall affects ventilators manufactured by Respironics California, Inc. and distributed by Philips (China) Investment Co., Ltd., under the NMPA's regulatory oversight. The Class I designation signifies that the use of these devices could lead to serious adverse health consequences or even death. Specific details on affected models, specifications, and batch numbers are provided in the associated "E-Recall Event Report Form" and an attached PDF document. This proactive measure aims to remove the faulty devices from circulation and safeguard patient well-being.